The Clinical Audit in Pharmaceutical Development

個数:

The Clinical Audit in Pharmaceutical Development

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 216 p.
  • 言語 ENG
  • 商品コード 9780367399337
  • DDC分類 615.1901

Full Description

This blue-chip guide adds quality to the pharmaceutical clinical development process by detailing the need for, and stressing the importance of, an independent audit of clinical data to protect participants and validate study results.
Examines the use of personal computers, the Internet, and third-party organizations to assist in data validation!
Positioning the audit as the only reliable tool to verify that a drug has been shown to be safe and effective in clinical trials, The Clinical Audit in Pharmaceutical Development

recommends establishing auditing and quality assurance at the beginning of a clinical study

describes Good Clinical Practices (GCPs) and the role of regulatory agencies in the review, validation, and auditing processes

outlines the clinical process, from trial design through report writing

compares and contrasts United States and international regulatory statutes

identifies monitoring as the key to guaranteeing high-quality data

focuses on the role of the clinical audit in achieving unity in a multinational study

discusses the worldwide influence of the US Food and Drug Administration audit

analyzes findings from previous FDA clinical audits to reveal trends and future directions

provides guidelines for fraud detection and considers the ramifications of falsified data

and more!
Confirming that all clinical information has been properly collected and reported, The Clinical Audit in Pharmaceutical Development is a crucial reference for clinical and research pharmacists and pharmacologists; biostatisticians; clinical research associates, coordinators, and investigators; quality control, quality assurance, and regulatory compliance managers; and upper-level undergraduate and graduate students in these disciplines.

Contents

Introduction to the Clinical Development Process
Michael R. Hamrell
Statutory Requirements and Regulatory Guidance
Tammala Woodrum, Diana B. Lee, and Jon R. Wallace
Source Documentation: Clinical Auditors' Observations
Vernette J. Molloy and Douglas R. Mackintosh
Quality Assurance in Clinical Trials
Richard Kiernan
Standardizing Quality in International Studies
Marijke Korteweg
Good Clinical Practices and Computers
Tammala Woodrum
Food and Drug Administration Audit
Arthur M. Horowitz
GCP Compliance Assessed by Independent Auditing: International Similarities and Difference
W. Boyachuk and G. Ball
Fraud and Misconduct in Clinical Research
Frank Wells

Appendix: ENGAGE: European Network of GCP Auditors and Other GCP Experts

最近チェックした商品